Compare Stocks

Date Range: 

 LexaGeneAbingdon HealthVerici DxRelay MedicalSQI Diagnostics
SymbolCVE:LXGLON:ABDXLON:VRCIOTCMKTS:RYMDFCVE:SQD
Price Information
Current PriceC$0.59GBX 55.77GBX 67.50$0.25C$0.30
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.50.30.00.00.9
Analysis Score0.00.00.00.00.0
Community Score2.50.00.00.02.7
Dividend Score0.00.00.00.00.0
Ownership Score0.01.70.00.01.7
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapC$83.27 million£53.59 million£95.68 million$34.48 millionC$52.59 million
BetaN/AN/AN/A1.49N/A
Average Volume400,161501,902147,772144,578183,961
Sales & Book Value
Annual RevenueN/AN/AN/AN/AC$977,000.00
Price / SalesN/AN/AN/AN/A102.87
CashflowC$0.07 per shareN/AN/AN/AC$0.02 per share
Price / Cash7.88N/AN/AN/A19.33
Book ValueC$0.09 per shareN/AN/AN/AC$0.01 per share
Price / BookN/AN/AN/AN/A32.78
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.12)N/AN/AN/AC($0.04)
Trailing P/E RatioN/A0.000.000.00N/A
Forward P/E Ratio∞∞∞∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio16.27%N/AN/AN/A171.24%
Current Ratio19.13%N/AN/AN/A2.56%
Quick Ratio17.50%N/AN/AN/A2.31%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees36N/AN/AN/A42
Shares Outstanding114.36 million95.70 million141.75 million146.42 million340.69 million
Next Earnings DateN/AN/AN/A6/7/2021 (Estimated)5/27/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
SQI Diagnostics Announces New Corporate WebsiteSQI Diagnostics Announces New Corporate Website
prnewswire.com - February 18 at 6:20 PM
SQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund CompanySQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund Company
markets.businessinsider.com - February 10 at 9:02 AM
SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study | MorningstarSQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study | Morningstar
morningstar.com - January 26 at 8:38 PM
SQI Diagnostics Announces $4 Million Funding via Warrant Exercise by InsidersSQI Diagnostics Announces $4 Million Funding via Warrant Exercise by Insiders
prnewswire.com - December 30 at 7:49 PM
SQI Diagnostics Inc Stock , SQIDFSQI Diagnostics Inc Stock , SQIDF
markets.businessinsider.com - December 26 at 8:24 PM
News for SQI Diagnostics IncNews for SQI Diagnostics Inc
markets.businessinsider.com - December 25 at 8:09 AM
North America Autoimmune Disease Diagnostics Market Estimated To Exceed 6.5 Billion Dollars By 2026North America Autoimmune Disease Diagnostics Market Estimated To Exceed 6.5 Billion Dollars By 2026
marketwatch.com - December 18 at 2:27 PM
Worldwide Autoimmune Disease Diagnosis Industry to 2025 - Impact Analysis of COVID-19Worldwide Autoimmune Disease Diagnosis Industry to 2025 - Impact Analysis of COVID-19
marketwatch.com - December 11 at 11:46 PM
Localized Autoimmune Disease Diagnostics Market 2021 Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026Localized Autoimmune Disease Diagnostics Market 2021 Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026
marketwatch.com - December 11 at 11:46 PM
SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory SubmissionSQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory Submission
newswire.ca - October 26 at 9:20 AM
SQI Diagnostics Reports Third Quarter 2020 ResultsSQI Diagnostics Reports Third Quarter 2020 Results
finance.yahoo.com - August 27 at 10:56 AM
IIROC Trading Resumption - SQDIIROC Trading Resumption - SQD
markets.businessinsider.com - August 18 at 1:51 PM
Options Run Red-Hot After FireEyes Board of Directors UpdateOptions Run Red-Hot After FireEye's Board of Directors Update
news.yahoo.com - August 14 at 10:52 AM
Requirements for homebuyers ease after stress test rate fallsRequirements for homebuyers ease after stress test rate falls
sports.yahoo.com - August 14 at 10:52 AM
How Much Are SQI Diagnostics Inc. (CVE:SQD) Insiders Spending On Buying Shares?How Much Are SQI Diagnostics Inc. (CVE:SQD) Insiders Spending On Buying Shares?
finance.yahoo.com - August 12 at 4:44 PM
SQI Diagnostics Reports Second Quarter 2020 ResultsSQI Diagnostics Reports Second Quarter 2020 Results
www.prnewswire.com - May 28 at 9:26 AM
SQI Diagnostics Inc.SQI Diagnostics Inc.
www.barrons.com - April 25 at 11:32 PM
SQI Diagnostics Inc. to hold Annual and Special Meeting of Shareholders by Conference Call; Announces Management ChangesSQI Diagnostics Inc. to hold Annual and Special Meeting of Shareholders by Conference Call; Announces Management Changes
www.finanzen.ch - March 24 at 5:34 PM
One-hour coronavirus triage test developed by SQI Diagnostics to receive funding from University Health NetworkOne-hour coronavirus triage test developed by SQI Diagnostics to receive funding from University Health Network
www.prnewswire.com - March 24 at 12:33 PM
SQI Diagnostics Inc. Announces Stock Option GrantSQI Diagnostics Inc. Announces Stock Option Grant
www.newswire.ca - March 10 at 12:42 PM
SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement with Insider ParticipationSQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement with Insider Participation
www.newswire.ca - March 5 at 6:47 PM
SQI Diagnostics Reports First Quarter 2020 ResultsSQI Diagnostics Reports First Quarter 2020 Results
www.prnewswire.com - February 27 at 1:20 PM
SQI Diagnostics Inc. Announces Extension of Debentures and Additional Debt FinancingSQI Diagnostics Inc. Announces Extension of Debentures and Additional Debt Financing
www.benzinga.com - January 30 at 9:35 AM
How SQI Diagnostics Inc. (CVE:SQD) Can Impact Your Portfolio VolatilityHow SQI Diagnostics Inc. (CVE:SQD) Can Impact Your Portfolio Volatility
finance.yahoo.com - November 28 at 6:45 PM
SQI Diagnostics Inc. Announces Closing of Second and Final Tranche of Private PlacementSQI Diagnostics Inc. Announces Closing of Second and Final Tranche of Private Placement
markets.businessinsider.com - October 22 at 5:38 PM
DateCompanyBrokerageAction
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.